 Home > Active Ingredient News > Immunology News > JEADV: 1-year effect study of Guselkumab in the treatment of psoriasis

JEADV: 1-year effect study of Guselkumab in the treatment of psoriasis

 Last Update: 2022-08-16
 Source: Internet
 Author: User

Tags

betamethasone psoriasis

sea life

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Psoriasis is a chronic systemic inflammatory disease that requires lifelong treatment for many patients to control the disease and its associated complicatio.

Guselkumab is a fully human monoclonal antibody that binds to the p19 subunit of interleuk.

Persistent is a non-interventional study investigating the long-term efficacy, safety and HRQOL of Guselkumab and Ustekinumab in routine clinical practice in patients with moderate to severe psorias.

method

Guselkumab was administered to patients (≥18 years of age) according to clinical practi.

result

Overall, 303 patients were enrolled and treated with Guselkum.

Conclusions: In conclusion, PERSIST is a large, authentic study that provides important evidence for the efficacy and safety of guselkumab outside of randomized controlled tria.

Source: Gerdes S, Asadullah K, Hoffmann M, Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkum.

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.